Amaryl: Effective Glycemic Control for Type 2 Diabetes - Evidence-Based Review

Product Description Amaryl, known generically as glimepiride, is a modern sulfonylurea oral antihyperglycemic agent. It is classified as a third-generation sulfonylurea and is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Unlike older sulfonylureas, glimepiride demonstrates a more pancreas-selective action with potentially lower cardiovascular risk and a once-daily dosing regimen that enhances patient adherence. It works primarily by stimulating the release of insulin from functional pancreatic beta cells.